Clinical trial Recruiting at 1 site Observational Ages 18 to 80

Improving prevention and treatment strategies for cardiomyopathy patients

Official title: Risk Stratification and New Early Prevention and Treatment Strategies for Patients With Cardiomyopathy (STRENGTH Trial): a National Multi-center, Retrospective-prospective, Cohort Study

Run by First Affiliated Hospital Xi'an Jiaotong University · NCT06352320 · Data updated 2026-11-12

This study is trying to gather information from cardiomyopathy patients to find better ways to prevent and treat their condition.

More Cardiomyopathies trials

Quick facts

Study typeObservational
Ages18 Years to 80 Years
SexAll
Enrollment500 (estimated)
SponsorFirst Affiliated Hospital Xi'an Jiaotong University
Academic / other
Locations1 site (Xi'an, Shaanxi)
StatusRecruiting
StartedMay 9, 2024
Main results expectedAugust 31, 2030
Study endsAugust 31, 2032
Registry record updatedJuly 12, 2024
Trial IDNCT06352320 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults over 18 years old with a confirmed diagnosis of cardiomyopathy.

Probably not a fit

Patients with incomplete clinical data or those who do not consent to participate will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to create a natural population cohort of patients with various types of cardiomyopathy by enrolling participants from multiple centers. It will collect clinical data and biological samples from surgical patients to develop a prognostic system for cardiomyopathy. The study seeks to optimize risk stratification and explore new strategies for early prevention and treatment, ultimately enhancing the diagnosis and treatment efficiency for cardiomyopathy patients.

Why it matters

Potential benefit: If successful, this study could lead to improved early prevention and treatment strategies for patients with cardiomyopathy.

How similar studies have gone: While there have been studies focusing on cardiomyopathy, this approach of creating a comprehensive prognostic system is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age \>18 years old.
* The diagnosis of cardiomyopathy was confirmed by cardiac ultrasound, electrocardiogram, magnetic resonance angiography, pathological examination and gene sequencing.
* Patients or their families agreed to participate in the study and authorized informed consent.

Exclusion Criteria:

* Incomplete clinical data.
* Do not agree to the inclusion or refuse to authorize the informed consent.

Where it's running

  • First Affiliated Hospital of Xi'an Jiantong University
    Xi'an, Shaanxi, China
    Recruiting

Study contacts

  • Principal investigator: Yang Yan — First Affiliated Hospital Xi'an Jiaotong University
  • Study coordinator: Yang Yan
  • Email: yangyan3@xjtu.edu.cn
  • Phone: +862985323869

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Myocardial Energetics Across Cardiovascular Disease Spectrum Using 31P-MRS

    Researchers are testing whether phosphorus-31 magnetic resonance spectroscopy (31P-MRS) can map heart energy metabolism across healthy people and patients with various heart conditions.

    Recruiting Chinese Academy of Medical Sciences, Fuwai Hospital · Beijing · NCT07912086

  • Liver and Coagulation Markers in ATTR Cardiac Amyloidosis

    This study tests liver function and blood-clotting markers in people with ATTR-CA to see if they reflect disease severity and progression.

    Recruiting University of Messina · Messina, Sicily · NCT07766135

  • RHYthm and Myocardial Function Relationship in Heart Disease

    This study tests how heart rhythm patterns relate to heart muscle function in adults with arrhythmias or cardiomyopathy.

    Recruiting Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Roma · NCT07491237

  • Multimodal analysis of heart biopsy samples

    This project will take one extra small heart biopsy during a clinically needed procedure to test whether detailed molecular and immune analyses can find disease-specific signatures in adults with cardiomyopathies, myocarditis, cardiac amyloidosis, or after heart transplant.

    Recruiting University Hospital, Essen · Essen, North Rhine-Westphalia · NCT07359690

  • Electrophysiological mapping to predict sudden cardiac death risk

    It will test whether detailed electrical mapping of the left ventricle can better predict dangerous ventricular arrhythmias in adults with ischemic or non-ischemic cardiomyopathy and LVEF under 50% who are not already ICD candidates.

    Recruiting at 3 sites University Hospital, Bordeaux · Clermont-Ferrand and 2 other locations · NCT07020702

  • Using retinal photographs to assess cardiovascular disease risk in heart failure patients

    This study is testing if looking at retinal photographs can help predict the risk of heart problems in people who have recently been diagnosed with heart failure.

    Recruiting Yonsei University · Seoul · NCT06978998

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.